Relmada Therapeutics to Present at Biotech Showcase 2019
Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that it will present at Biotech Showcase 2019 to be held January 7-9, 2019, at the Hilton San Francisco Union Square.
Details of Relmada's presentation are as follows:
Date: Monday, January 7, 2019
Venue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street, San Francisco, CA (Unite...